Sheila M. Hegde

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.1K citations · Full text

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +2

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy

Carolyn Y. Ho, Matthew E. Mealiffe, Richard G. Bach et al. · Journal of the American College of Cardiology · 2020 · 316 citations · Full text

Plant-based diets, pescatarian diets and COVID-19 severity: a population-based case–control study in six countries

Hyunju Kim, Casey M. Rebholz, Sheila M. Hegde et al. · BMJ Nutrition Prevention & Health · 2021 · 182 citations · Full text

Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy

Sheila M. Hegde, Steven J. Lester, Scott D. Solomon et al. · Journal of the American College of Cardiology · 2021 · 175 citations · Full text

Cardiomyopathy, Echocardiographic Features, Cardiovascular Disease +8

Influenza Vaccine in Heart Failure

Daniel Modin, Mads Emil Jørgensen, Gunnar Gislason et al. · Circulation · 2019 · 166 citations